litlas
ログインアカウント作成

Yuquan Wei

1994–2025 年に発表

265
論文数
35,488
被引用数
106
h 指数
250
i10 指数

被引用数

Yuquan Wei の年別被引用数1988 年: 被引用 1 件1989 年: 被引用 1 件1992 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 5 件1997 年: 被引用 7 件1998 年: 被引用 6 件1999 年: 被引用 11 件2000 年: 被引用 15 件2001 年: 被引用 7 件2002 年: 被引用 7 件2003 年: 被引用 11 件2004 年: 被引用 12 件2005 年: 被引用 8 件2006 年: 被引用 14 件2007 年: 被引用 9 件2008 年: 被引用 15 件2009 年: 被引用 29 件2010 年: 被引用 38 件2011 年: 被引用 44 件2012 年: 被引用 101 件2013 年: 被引用 91 件2014 年: 被引用 143 件2015 年: 被引用 169 件2016 年: 被引用 206 件2017 年: 被引用 251 件2018 年: 被引用 278 件2019 年: 被引用 951 件2020 年: 被引用 1,517 件2021 年: 被引用 2,059 件2022 年: 被引用 1,864 件2023 年: 被引用 1,720 件2024 年: 被引用 2,919 件2025 年: 被引用 1,587 件2026 年: 被引用 43 件1990〜1991 年は被引用が無いため表示していません1993〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 6,569 件、この内訳の 33.9%アメリカ合衆国: 引用元論文 2,987 件、この内訳の 15.4%インド: 引用元論文 852 件、この内訳の 4.4%イギリス: 引用元論文 576 件、この内訳の 3%ドイツ: 引用元論文 552 件、この内訳の 2.9%イタリア: 引用元論文 514 件、この内訳の 2.7%韓国: 引用元論文 506 件、この内訳の 2.6%イラン: 引用元論文 471 件、この内訳の 2.4%オーストラリア: 引用元論文 407 件、この内訳の 2.1%日本: 引用元論文 336 件、この内訳の 1.7%スペイン: 引用元論文 328 件、この内訳の 1.7%カナダ: 引用元論文 324 件、この内訳の 1.7%
0%33.9%その他 25.5%

機関

分野

  • Biochemistry, Genetics and Molecular Biology36.3%
  • Medicine35.8%
  • Immunology and Microbiology10.7%
  • Engineering4.3%
  • Materials Science3.1%
  • Computer Science1.8%
  • その他8%

トピック

  • RNA Interference and Gene Delivery2.4%
  • Immunotherapy and Immune Responses2.4%
  • SARS-CoV-2 and COVID-19 Research2.1%
  • Immune cells in cancer1.9%
  • Cancer Immunotherapy and Biomarkers1.7%
  • Autophagy in Disease and Therapy1.7%
  • その他87.8%

共著者

全論文

検索で開く
  1. Targeting TGF-β signal transduction for fibrosis and cancer therapy

    著者: Dandan Peng, Minyang Fu, Manni Wang, Yuquan Wei, Xiawei Wei - Molecular Cancer 2022 被引用: 1,008

  2. Vaccine adjuvants: mechanisms and platforms

    著者: Tingmei Zhao, Yulong Cai, Yujie Jiang, Xuemei He, Yuquan Wei, Yifan Yu, Xiaohe Tian - Signal Transduction and Targeted Therapy 2023 被引用: 843

  3. Cancer vaccines as promising immuno-therapeutics: platforms and current progress

    著者: Jian Liu, Minyang Fu, Manni Wang, Dandan Wan, Yuquan Wei, Xiawei Wei - Journal of Hematology & Oncology 2022 被引用: 694

  4. Targeting PI3K in cancer: mechanisms and advances in clinical trials

    著者: Jing Yang, Ji Nie, Xuelei Ma, Yuquan Wei, Yong Peng, Xiawei Wei - Molecular Cancer 2019 被引用: 1,560

  5. cGAS-STING pathway in cancer biotherapy

    著者: Yang Wang, Jingwen Luo, Aqu Alu, Xuejiao Han, Yuquan Wei, Xiawei Wei - Molecular Cancer 2020 被引用: 387

  6. Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

    著者: You Lü, Jianxin Xue, Tao Deng, Xiaojuan Zhou, Kun Yu, Lei Deng, Meijuan Huang, Xin Yi, Maozhi Liang, Yu Wang, Haige Shen, Ruizhan Tong, Wenbo Wang, Li Li, Jin Sook Song, Jing Li, Xiaoxing Su, Zhenyu Ding, Youling Gong, Jiang Zhu, Yongsheng Wang, Bingwen Zou, Yan Zhang, Yanying Li, Lin Zhou, Yongmei Liu, Min Yu, Yuqi Wang, Xuanwei Zhang, Limei Yin, Xuefeng Xia, Yong Zeng, Qiao Zhou, Binwu Ying, Chong Chen, Yuquan Wei, Weimin Li, Tony Mok - Nature Medicine 2020 被引用: 537

  7. mRNA vaccine: a potential therapeutic strategy

    著者: Yang Wang, Ziqi Zhang, Jingwen Luo, Xuejiao Han, Yuquan Wei, Xiawei Wei - Molecular Cancer 2021 被引用: 410

  8. Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting

    著者: Maosen Xu, Yang Wang, Ruolan Xia, Yuquan Wei, Xiawei Wei - Cell Proliferation 2021 被引用: 377

  9. Targeting the tumor stroma for cancer therapy

    著者: Maosen Xu, Tao Zhang, Ruolan Xia, Yuquan Wei, Xiawei Wei - Molecular Cancer 2022 被引用: 352

  10. Role of lysosomes in physiological activities, diseases, and therapy

    著者: Ziqi Zhang, Pengfei Yue, Tianqi Lu, Yang Wang, Yuquan Wei, Xiawei Wei - Journal of Hematology & Oncology 2021 被引用: 348

  11. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications

    著者: Chenjing Zhu, Yuquan Wei, Xiawei Wei - Molecular Cancer 2019 被引用: 503

  12. CCL5/CCR5 axis in human diseases and related treatments

    著者: Zhen Zeng, Tianxia Lan, Yuquan Wei, Xiawei Wei - Genes & Diseases 2021 被引用: 400

  13. Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer

    著者: Zhenyu Ding, Qing Li, Rui Zhang, Li Xie, Yang Shu, Song Gao, Peipei Wang, Xiaoqing Su, Yun Qin, Yuelan Wang, Juemin Fang, Zhongzheng Zhu, Xuyang Xia, Guochao Wei, Hui Wang, Hong Qian, Xianling Guo, Zhibo Gao, Yu Wang, Yuquan Wei, Qing Xu, Heng Xu, Li Yang - Signal Transduction and Targeted Therapy 2021 被引用: 263

  14. Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin

    著者: Yuan Cheng, Fei Mo, Qingfang Li, Xuejiao Han, Houhui Shi, Siyuan Chen, Yuquan Wei, Xiawei Wei - Molecular Cancer 2021 被引用: 205

  15. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy

    著者: Xiangrong Song, Chao Liu, Ning Wang, Hai Huang, Siyan He, Changyang Gong, Yuquan Wei - Advanced Drug Delivery Reviews 2020 被引用: 207

  16. Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials

    著者: Yanlin Song, Zhenfei Bi, Yu Liu, Furong Qin, Yuquan Wei, Xiawei Wei - Genes & Diseases 2022 被引用: 202

  17. Epigenetic regulation of macrophages: from homeostasis maintenance to host defense

    著者: Siyuan Chen, Jing Yang, Yuquan Wei, Xiawei Wei - Cellular and Molecular Immunology 2019 被引用: 306

  18. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

    著者: H. J. Yang, Wei Wang, Zimin Chen, Shuaiyao Lu, Fanli Yang, Zhenfei Bi, Linlin Bao, Fei Mo, Xue Li, Yong Huang, Weiqi Hong, Yun Yang, Yuan Zhao, Fei Ye, Sheng Lin, Wei Deng, Hua Chen, Lei Hong, Ziqi Zhang, Min Luo, Hong Gao, Yue Zheng, Yanqiu Gong, Xiaohua Jiang, Yanfeng Xu, Qi Lv, Dan Li, Manni Wang, Fengdi Li, Shunyi Wang, Guanpeng Wang, Pin Yü, Yajin Qu, Li Yang, Hongxin Deng, Aiping Tong, Jiong Li, Zhenling Wang, Jinliang Yang, Guobo Shen, Zhiwei Zhao, Yuhua Li, Jingwen Luo, Hongqi Liu, Wenhai Yu, Mengli Yang, Jingwen Xu, Junbin Wang, Haiyan Li, Haixuan Wang, Dexuan Kuang, Panpan Lin, Zhengtao Hu, Wei Guo, Wei Cheng, Yanlin He, Xiangrong Song, Chong Chen, Zhihong Xue, Shaohua Yao, Lu Chen, Xuelei Ma, Siyuan Chen, Maling Gou, Weijin Huang, Youchun Wang, Changfa Fan, Zhixin Tian, Ming Shi, Fu‐Sheng Wang, Lunzhi Dai, Min Wu, Gen Li, Guangyu Wang, Yong Peng, Zhiyong Qian, Canhua Huang, Johnson Yiu‐Nam Lau, Zhenglin Yang, Yuquan Wei, Xiaobo Cen, Xiaozhong Peng, Chuan Qin, Kang Zhang, Guangwen Lu, Xiawei Wei - Nature 2020 被引用: 849

  19. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention

    著者: Ling Li, Ning Wang, Xun Jin, Rui Deng, Shihong Nie, Lu Sun, Qinjie Wu, Yuquan Wei, Changyang Gong - Biomaterials 2014 被引用: 450

  20. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer

    著者: Zhen Zeng, Minyang Fu, Yuan Hu, Yuquan Wei, Xiawei Wei, Min Luo - Molecular Cancer 2023 被引用: 120

  21. SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model

    著者: Jingxin Qiao, Yueshan Li, Rui Zeng, Feng‐Liang Liu, Rong‐Hua Luo, Chong Huang, Yifei Wang, Jie Zhang, Baoxue Quan, C. Shen, Xin Mao, Xinlei Liu, Weining Sun, Wei Yang, Xincheng Ni, Kai Wang, Ling Xu, Zilei Duan, Qing-Cui Zou, Hai-Lin Zhang, Wang Qu, Yanghaopeng Long, Minghua Li, Ruicheng Yang, Xiaolong Liu, Jing You, Yangli Zhou, Rui Yao, Wenpei Li, Jing-Ming Liu, Pei Chen, Yang Liu, Guifeng Lin, Xin Yang, Jun Zou, Linli Li, Yiguo Hu, Guangwen Lu, Weimin Li, Yuquan Wei, Yong‐Tang Zheng, Jian Lei, Shengyong Yang - Science 2021 被引用: 450

  22. Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants

    著者: Na Fan, Kepan Chen, Rong Zhu, Zhongwei Zhang, Hai Huang, Shugang Qin, Qian Zheng, Zhongshan He, Xi He, Wen Xiao, Yupei Zhang, Yongjun Gu, Changchun Zhao, Yongmei Liu, Xin Jiang, Shuai Cheng Li, Yuquan Wei, Xiangrong Song - Science Advances 2022 被引用: 96

  23. KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming

    著者: Feifei Na, Xiangyu Pan, Jingyao Chen, Xuelan Chen, Manli Wang, Pengliang Chi, Liting You, Lanxin Zhang, Ailing Zhong, Lei Zhao, Siqi Dai, Mengsha Zhang, Yiyun Wang, Bo Wang, Jianan Zheng, Yuying Wang, Jing Xu, Jian Wang, Baohong Wu, Mei Chen, Hongyu Liu, Jianxin Xue, Meijuan Huang, Youling Gong, Jiang Zhu, Lin Zhou, Yan Zhang, Min Yu, Panwen Tian, Mingyu Fan, Zhenghao Lu, Zhihong Xue, Yinglan Zhao, Hanshuo Yang, Chengjian Zhao, Yuan Wang, Junhong Han, Shengyong Yang, Dan Xie, Lu Chen, Qian Zhong, Mu‐Sheng Zeng, Scott W. Lowe, You Lü, Yu Liu, Yuquan Wei, Chong Chen - Nature Cancer 2022 被引用: 120

  24. mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids

    著者: Kepan Chen, Na Fan, Hai Huang, Xin Jiang, Shugang Qin, Wen Xiao, Qian Zheng, Yupei Zhang, Xing Duan, Zeyi Qin, Yongmei Liu, Jun Zeng, Yuquan Wei, Xiangrong Song - Advanced Functional Materials 2022 被引用: 107